Blood donation and Iron supplementation in Nigeria : THE RANFERON STUDY

Iron supplementation and blood donation in Nigeria: Effect on haemoglobin, red cell indices, and iron stores – The Ranferon study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202106811797550

Enrollment

Registered

2021-06-02

Start date

2020-02-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematological Disorders

Interventions

None

Oral Ranferon

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Blood donors aged from 18-65 years

Exclusion criteria

Exclusion criteria: Pregnancy Those on iron supplements including multivitamins containing iron and refuse to stop do so for the 6 weeks of the study, Those with baseline ferritin >300 ug/L (to exclude individuals with hemochromatosis} w

Design outcomes

Primary

Measure	Time frame
The primary outcome measure is effect of 6 weeks daily iron supplementation on the recovery time of haemoglobin levels, red cell indices and iron stores post donation of one unit of whole blood.	—

Secondary

Measure	Time frame
The secondary outcomes were participants’ adherence and compliance to iron supplementation dosage using Modified Morisky score (MMS) and self-reported GIT side effects of RanferonTM.	—

Countries

Nigeria

Contacts

Public ContactJerry Egbeaso

Research assistant

egbeasojerry@gmail.com2348037399094

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026